Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Safety, tolerability, and immunogenicity of an inactivate... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
0
Authors
Yanjun Zhang
20 more
Yanjun Zhang
•
Gang Zeng
18 more
•
Fengcai Zhu
Published
November 19, 2020
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Infectious Diseases
Topics
Medicine
Immunology
Pathology
Internal Medicine
Infectious Diseases
Show all topics
DOI
10.1016/s1473-3099(20)30843-4
License
other-oa
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Infectious Diseases
Topics
Medicine
Immunology
Pathology
Internal Medicine
Infectious Diseases
Show all topics
DOI
10.1016/s1473-3099(20)30843-4
License
other-oa
